Search

everythinglearnresearchcommunity

for

Search:↓

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

ErbB2 signaling is crucial for skin cell growth and cancer development in mice.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

The HCR gene contributes to psoriasis risk.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

K6 gene expression can be controlled and manipulated in mice for studying skin disorders.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

ODC transgenic mice can model human hair loss with skin lesions.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

The study created a mouse model that survives longer and shows fewer symptoms of pemphigus vulgaris.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Transgenic sheep embryos with a specific promoter were successfully created, but more research is needed for gene expression in hair follicles.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Transgender women can still get testicular cancer, so proper screening is important.

Hair transplantation can help transgender patients affirm their gender identity.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Testosterone increases hair growth and acne in transgender men.

Minoxidil boosts hair growth in genetically modified mice.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.